F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine

U.S. Health Officials Defend Rejection of Moderna’s Flu Vaccine

Moderna's CEO said the company doesn't plan to invest in new late-stage vaccine trials due to growing opposition to immunizations from US officials

Moderna curbing investments in vaccine trials due to US backlash, CEO tells Bloomberg TV